AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma

ABSTRACT: RATIONALE: Monoclonal antibodies, such as AMG-479, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. PURPOSE: This phase I trial is studying the side effects and best dose of AMG-479 in treating patients with advanced solid tumors or non-Hodgkin lymphoma.

DISEASE(S): Prostatic Neoplasms,Sarcoma,Prostate Cancer,Small Intestine Cancer,Angioimmunoblastic T-cell Lymphoma,Intestinal Neoplasms,Lymphoma,Unspecified Adult Solid Tumor, Protocol Specific

PROVIDER: 2046682 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR